Search results for MLH1 antibody

Anti-MLH1 Antibody (R3K35), AntibodySystem, RHE27602

Anti-MLH1 Antibody (R3K36), AntibodySystem, RHE27603

Anti-MLH1 Antibody (R3K37), AntibodySystem, RHE27604

Anti-MLH1 Antibody (R3K38), AntibodySystem, RHE27605

Anti-MLH1 Antibody (R3K39), AntibodySystem, RHE27606

Anti-MLH1 Antibody (R1V73), AntibodySystem, RHE27601

PE Anti-MLH1 antibody [EPR20522], Abcam, AB303187

This conjugated primary antibody is “made to order” and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link® conjugation technology, Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. This product is FOR RESEARCH USE ONLY. For commercial use, please contact [email protected]. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-MLH1 antibody [EPR3894], Abcam, AB303047

How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

MLH1 Antibody (YA3996)(PBS only), MedChemexpress, HY-P84299A

MLH1 Antibody (YA3996) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MLH1.

Anti-MLH1 antibody [EPR26314-1], Abcam, AB315011

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .